Welcome to our dedicated page for Health In Tech SEC filings (Ticker: HIT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to follow Health In Tech, Inc.’s rapid insurtech growth? Investors usually begin with the numbers: recurring SaaS fees, broker commission margins and capitalised software costs. Our SEC dashboard surfaces those details instantly, whether you are scanning a Health In Tech quarterly earnings report 10-Q filing for segment revenue or digging into an 8-K material events explained note on a new carrier partnership. No more endless scrolling through EDGAR—just ask and the answers appear.
Powered by Stock Titan’s AI, the platform delivers plain-English explanations of every form. Need Health In Tech insider trading Form 4 transactions before market open? You’ll receive real-time alerts, plus an at-a-glance chart of executive stock transactions Form 4. Wondering how proxy statement executive compensation ties to underwriting profitability? Our AI links the numbers, highlights key clauses and tags peer comparisons. Each filing—10-K, 10-Q, 8-K or S-1—is summarised so you can understand Health In Tech SEC documents with AI instead of poring over accounting jargon.
Because HIT operates at the junction of insurance and healthcare tech, disclosures often address data-privacy liabilities, HIPAA compliance spending and vertical-integration risks. Our earnings report filing analysis identifies those red flags, while the Health In Tech annual report 10-K simplified module breaks down revenue recognition and long-term contract assumptions. Use the timeline view to track Health In Tech Form 4 insider transactions real-time, compare quarter-over-quarter trends, or export tables for valuation models. Comprehensive coverage, live updates and expert context—everything you need to understand this insurtech’s story without the paperwork burden.
Health In Tech director William D. Howard acquired 128,474 shares of Class A Common Stock on June 23, 2025 at $0.62 per share through a restricted stock grant under the company's Equity Incentive Plan.
Key details of the restricted stock grant:
- Vesting conditions: Full vesting after one year of service from December 23, 2024
- Alternative partial vesting: At first shareholders' meeting based on service period ratio
- Vesting requirement: Continuous service through vesting date
- Total value of grant: Approximately $79,654
This Form 4 filing was signed by Howard on June 25, 2025, meeting the SEC's two-day reporting requirement for insider transactions. The shares are held directly by the reporting person.
Timothy Hayes, Director of Health In Tech (HIT), acquired 128,474 shares of Class A Common Stock on June 23, 2025, at a price of $0.62 per share through a restricted stock grant under the company's Equity Incentive Plan.
Key vesting terms:
- Full vesting after one year of service from December 23, 2024
- Alternative partial vesting at first shareholders' meeting based on service time ratio
- Vesting conditional on continuous service through vesting date
The transaction was reported via Form 4 filing on June 25, 2025, within the required reporting window. This equity grant aligns the director's interests with shareholders and serves as part of the company's executive compensation strategy.
Director Sanjay Shrestha of Health In Tech received a grant of 128,474 restricted shares of Class A Common Stock at $0.62 per share on June 23, 2025, as reported in this Form 4 filing.
Key details of the stock grant:
- Shares were granted under the Health in Tech Equity Incentive Plan
- Vesting conditions include: - Full vesting after one year of service from April 8, 2025, or - Partial vesting at first shareholders' meeting based on service period ratio
- Direct ownership form of securities
- Vesting subject to continuous service requirement
This equity grant appears to be part of director compensation and aligns the director's interests with shareholders through a one-year vesting schedule.
Director Chike Umemezia of Health In Tech received a grant of 128,474 restricted shares of Class A Common Stock on June 23, 2025, at a price of $0.62 per share under the company's Equity Incentive Plan.
The restricted shares have specific vesting conditions:
- Full vesting after one year of service from December 23, 2024, or
- Partial vesting at the first shareholders' meeting based on a pro-rata calculation of service time (up to 12 months) from December 23, 2024
The grant represents a direct ownership position and requires continuous service through the vesting date. This equity compensation aligns the director's interests with shareholders and serves as a retention mechanism through the vesting schedule.
FAQ
What is the current stock price of Health In Tech (HIT)?
What is the market cap of Health In Tech (HIT)?
What is the core business of Health In Tech, Inc.?
How does Health In Tech integrate technology into its operations?
What benefits does Health In Tech offer to insurance service providers?
How does vertical integration play a role in HIT's business model?
How does Health In Tech differentiate itself from competitors?
Who are the primary customers of Health In Tech?
What industry challenges does Health In Tech address?
Can you explain the role of AI in Health In Tech's marketplace?
